Related Experiment Video
Updated: Sep 5, 2025
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.4K
Lipoprotein(a): Insights for the Practicing Clinician
Pyotr Telyuk1, David Austin1, Ahai Luvai2
1Academic Cardiovascular Unit, The James Cook University Hospital, Middlesbrough TS4 3BW, UK.
Journal of Clinical Medicine
|July 9, 2022
Summary
Elevated Lipoprotein(a) (Lp(a)) levels are linked to cardiovascular disease and calcific aortic stenosis. Emerging therapies targeting Lp(a) show promise for managing these conditions.
Area of Science:
- Cardiology
- Biochemistry
- Genetics
Background:
- Lipoprotein(a) (Lp(a)) was discovered in 1963, but its full physiological and pathological roles are still under investigation.
- Epidemiological studies consistently show a strong correlation between elevated Lp(a) levels and increased risk of cardiovascular disease (CVD).
- Recent research highlights Lp(a)'s association with the incidence and progression of calcific aortic stenosis.
Purpose of the Study:
- To review the critical role of Lipoprotein(a) in the development of cardiovascular disease.
- To discuss the potential impact of novel therapeutic strategies aimed at reducing serum Lp(a) concentrations.
- To emphasize the clinical significance of Lp(a) testing in at-risk populations.
Main Methods:
- This review synthesizes findings from multiple population-based studies and clinical research.
- It examines epidemiological data linking Lp(a) levels to cardiovascular events and aortic stenosis.
- The review also considers emerging therapeutic approaches targeting Lp(a).
Main Results:
- Elevated Lp(a) is a significant independent risk factor for atherosclerotic cardiovascular disease.
- Lp(a) levels are directly associated with the development and progression of calcific aortic stenosis.
- New therapies capable of specifically lowering Lp(a) are becoming available.
Conclusions:
- Lipoprotein(a) plays a crucial role in cardiovascular pathology, necessitating increased clinical attention.
- Novel therapies targeting Lp(a) offer a promising avenue for CVD prevention and treatment.
- International guidelines now recommend Lp(a) testing for specific patient groups due to its clinical importance.
Related Concept Videos
01:26Atherosclerosis III: Management
31
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
290
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
290
01:30Atherosclerosis I: Introduction
73
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
73
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
853
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
853
01:26Coronary Artery Disease IV: Preventive Measures
31
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
01:23Atherosclerosis IV: Nursing Management
50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50